Literature DB >> 7577455

The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.

J Leveckis1, N J Brown, M W Reed.   

Abstract

The effect of photodynamic therapy on normal striated muscle was investigated using 30 adult male rats. Animals were divided into six groups. Three control groups received phosphate-buffered saline by gavage and violet light at 105, 178 and 300 mW cm-2 respectively. Three experimental groups received aminolaevulinic acid (ALA; 200 mg kg-1) and violet light at 105, 178 and 300 mW cm-2 respectively. After exposure of the cremaster muscle animals were allowed to equilibrate and vessel diameters and bloodflow assessed. Following photoactivation measurements were taken every 10 min over a 2 h period. Photoactivation of experimental groups at the two higher power densities resulted in an initial decrease in both arteriolar and venular diameters, and a concomitant decrease in blood flow. The magnitude of these changes and the degree of recovery by the end of the observation period was related to power density. No effects were observed in the control groups. These results suggest that microcirculatory damage may contribute to the mechanism of action of photodynamic therapy with ALA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577455      PMCID: PMC2033946          DOI: 10.1038/bjc.1995.473

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo.

Authors:  R H Pottier; Y F Chow; J P LaPlante; T G Truscott; J C Kennedy; L A Beiner
Journal:  Photochem Photobiol       Date:  1986-11       Impact factor: 3.421

2.  An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy.

Authors:  S Baez
Journal:  Microvasc Res       Date:  1973-05       Impact factor: 3.514

3.  Photoradiation therapy of endobronchial lung cancers employing the photodynamic action of hematoporphyrin derivative.

Authors:  O J Balchum; D R Doiron; G C Huth
Journal:  Lasers Surg Med       Date:  1984       Impact factor: 4.025

4.  Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells.

Authors:  J R Shulok; J E Klaunig; S H Selman; P J Schafer; P J Goldblatt
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

5.  Jejunal blood flow after exposure to light in rats injected with hematoporphyrin derivative.

Authors:  S H Selman; M Kreimer-Birnbaum; P J Goldblatt; T S Anderson; R W Keck; S L Britton
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

6.  Hematoporphyrin derivative photochemotherapy of experimental bladder tumors.

Authors:  S H Selman; A J Milligan; M Kreimer-Birnbaum; R W Keck; P J Goldblatt; S L Britton
Journal:  J Urol       Date:  1985-02       Impact factor: 7.450

7.  Photodynamic treatment of transplantable bladder tumors in rodents after pretreatment with chloroaluminum tetrasulfophthalocyanine.

Authors:  S H Selman; M Kreimer-Birnbaum; K Chaudhuri; G M Garbo; D A Seaman; R W Keck; E Ben-Hur; I Rosenthal
Journal:  J Urol       Date:  1986-07       Impact factor: 7.450

8.  Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers.

Authors:  W M Star; H P Marijnissen; A E van den Berg-Blok; J A Versteeg; K A Franken; H S Reinhold
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

9.  Complications of whole bladder dihematoporphyrin ether photodynamic therapy.

Authors:  J I Harty; M Amin; T J Wieman; M T Tseng; D Ackerman; W Broghamer
Journal:  J Urol       Date:  1989-06       Impact factor: 7.450

10.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy.

Authors:  B W Henderson; S M Waldow; T S Mang; W R Potter; P B Malone; T J Dougherty
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

View more
  7 in total

1.  Laser speckle imaging of dynamic changes in flow during photodynamic therapy.

Authors:  B Kruijt; H S de Bruijn; A van der Ploeg-van den Heuvel; H J C M Sterenborg; D J Robinson
Journal:  Lasers Med Sci       Date:  2006-10-13       Impact factor: 3.161

2.  Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.

Authors:  Allison Marrero; Theresa Becker; Ulas Sunar; Janet Morgan; David Bellnier
Journal:  Photochem Photobiol       Date:  2011-06-13       Impact factor: 3.421

3.  Monitoring blood flow responses during topical ALA-PDT.

Authors:  Theresa L Becker; Anne D Paquette; Kenneth R Keymel; Barbara W Henderson; Ulas Sunar
Journal:  Biomed Opt Express       Date:  2010-12-15       Impact factor: 3.732

4.  Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX.

Authors:  L Wyld; J L Burn; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Comparison of delta-aminolaevulinic acid and its methyl ester as an inducer of porphyrin synthesis in cultured cells.

Authors:  R Washbrook; P A Riley
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats.

Authors:  K Svanberg; D L Liu; I Wang; S Andersson-Engels; U Stenram; S Svanberg
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

7.  Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours.

Authors:  D K Kelleher; J Bastian; O Thews; P Vaupel
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.